Erck Stanley C's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Oct 2, 2024
- Accession no.
- 0001415889-24-024454
- Filed
- Oct 2, 2024, 5:03 PM ET
- Trade date
- Oct 1-2, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $178.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Erck Stanley CCIK 0001342826 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | MOption exerciseAcquired | +26,082 | $0.04 | +$1,043.28 | 295,200 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −26,082 | $3.78 | −$98,589.96 | 269,118 | Direct | |
| Oct 2, 2024 | Common Stock | MOption exerciseAcquired | +21,607 | $0.04 | +$864.28 | 290,725 | Direct | |
| Oct 2, 2024 | Common Stock | SSaleDisposed | −21,607 | $3.71 | −$80,161.97 | 269,118 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | MOption exerciseDisposed | −26,082 | $0.00 | $0 | 69,296 | Direct | |
| Oct 2, 2024 | Common Stock | MOption exerciseDisposed | −21,607 | $0.00 | $0 | 47,689 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.